This editorial highlights the evolution of TAVI towards lower-risk populations, minimalist procedural approaches, and improved clinical outcomes over an 8-year period.
In the past decade transcatheter aortic valve implantation (TAVI) has become a life-saving, minimally invasive therapy for many patients with severe aortic valve stenosis. Initially TAVI was conceived as a last resort for inoperable patients or as an alternative for individuals at high surgical risk, but soon patients with an intermediate surgical risk followed. After the success of large randomised PARTNER trials, the number of procedures increased rapidly
No takes yet. Share an insight, caveat, or question.
Kesteren et al. (2018) conducted an editorial in Severe aortic valve stenosis (n=1,000). Transcatheter aortic valve implantation (TAVI) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: